ArticleJAMA dermatology2026

Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.

Arash Mostaghimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.